The Medicare Replacement Drug Demonstration

Type: Completed Demos & Evaluation Reports
Year: 2005

This demonstration was mandated under sec.641 of the MMA. It covered certain oral and self-administrable drugs and biologicals that replaced the need for drugs covered under Medicare Part B. The demonstration began in Sept. 2004. The last date for submitting applications was Nov 30, 2005. As of that date, 42,200 beneficiaries were enrolled for coverage for drugs to treat cancer, rheumatoid arthritis, multiple sclerosis and other serious illnesses. The demonstration will end Dec. 31, 2005.

Downloads

• Drug List [PDF, 25KB] (PDF)
• English Brochure [PDF, 512KB] (PDF)
• Spanish Brochure [PDF, 318KB] (PDF)
• Cost Sharing [PDF, 383KB] (PDF)
• List of charitable organizations [PDF, 68KB] (PDF)
• Federal Register June 29, 2004 [PDF, 201KB] (PDF)
• Federal Register August 27, 2004 [PDF, 50KB] (PDF)
• Demonstration Evaluation [PDF, 37KB] (PDF)
• Demonstration Evaluation [ZIP, 8KB] (ZIP)
• Report to Congress [PDF, 1MB] (PDF)
• Cost-effectiveness of Biologic Therapies for Multiple Sclerosis [PDF, 6MB]
• Cost-effectiveness of Biologic Therapies for Rheumatoid Arthritis [PDF, 5MB]

Related Links

• Part 1. Gefitinib and Erlotinib for Non-Small Cell Lung Cancer
• Part 2. Imatinib for Gastrointestinal Stromal Tumors (GISTs)
• Part 3. Imatinib for Chronic Myeloid Leukemia (CML)
• Part 4. Thalidomide for Multiple Myeloma